Skip to content

Clinical trials

Lymphoproliferative Disorders trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoproliferative Disorders Country / region: Belgium Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20111
20121
20151
20171
20192
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated5
Active, not recruiting2
Completed2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pierre Fabre Medicament2
miRagen Therapeutics, Inc.2
Acerta Pharma BV1
Amgen1
Amgen Research (Munich) GmbH1
Ariad Pharmaceuticals1
Seagen Inc.1
Spectrum Pharmaceuticals, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoproliferative Disorders10
Lymphatic Diseases6
Immunoproliferative Disorders5
Lymphoma5
Lymphoma, Non-Hodgkin5
Neoplasms5
Immune System Diseases3
Lymphoma, T-Cell3
Epstein-Barr Virus Infections2
Hematologic Diseases2

Trials

Showing 26 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.